Dr. Giovannetti at the congress “In squadra si può vincere”, Carrara
Dr. Giovannetti participated to the congress organized by Dr. Mambrini on the role of a multidisciplinary approach for the treatment of pancreatic cancer.
Press release at:
Thanks to Dr. Mambrini and his team for the organization and longstanding collaboration on pharmacogenomics and new biomarkers studies in pancreatic cancer and cholangiocarcinoma, which already resulted in several articles, including:
Prognostic factors in gemcitabine–cisplatin polychemotherapy regimens in pancreatic cancer: XPD‐Lys751Gln polymorphism strikes back